FDA 483 - Central California Blood Center/ Clovis Donor Center - December 11, 2024

An FDA inspection of Central California Blood Center/Clovis Donor Center in Clovis, CA, identified two significant observations. The facility failed to provide adequate space for the orderly and clean storage of blood and blood components, leading to potential contamination risks. Additionally, phlebotomists were observed not consistently following written standard operating procedures for inverting sample tubes during blood collection, which could affect sample integrity.